Noor Fahitah Abu Hanipah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Noor Fahitah Abu Hanipah has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Norhafiza Razali
Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, Sungai Buloh 47000, Selangor, Malaysia
2 shared publications - Ahmad Nazrun Shuid
Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA (UITM), Jalan Hospital, Sungai Buloh 47000, Selangor, Malaysia
1 shared publication - Amy Suzana Abu Bakar
Institute of Medical Molecular Biotechnology (IMMB), Universiti Teknologi MARA (UiTM), 47000 Sungai Buloh, Malaysia
1 shared publication - Mohammad Daniel Shafiq Hassan
Institute of Medical Molecular Biotechnology (IMMB), Universiti Teknologi MARA (UiTM), 47000 Sungai Buloh, Malaysia
1 shared publication - Mohd Fahami Nur Azlina
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia
1 shared publication - Nafeeza Mohd Ismail
Centre for Neuroscience Research (NeuRon), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia
1 shared publication
Latest Publications
- Open Access
- 3 November 2025
- Published by Servicio de Publicaciones de la Universidad de Murcia in Revista Española de Educación Médica
- Vol. 6 (6)
Systematic review on safe prescribing training for medical students.
Introduction: Medication errors present a significant challenge to patient safety, stemming from inaccuracies in prescribing, dispensing, administration, and monitoring. These errors emphasise the urgent need to enhance safe prescribing training for medical students. This systematic review evaluates educational interventions aimed at improving prescribing competencies among medical undergraduates. Methods: A comprehensive search across Scopus, PubMed, Web of Science, ScienceDirect, and Google Scholar identified 16 primary studies that met the inclusion criteria. The interventions examined included case-based workshops, simulation-based training, e-learning platforms, interprofessional education, and pharmacist-led initiatives. Results: Findings consistently indicated that structured, longitudinal teaching, particularly when it integrates clinical relevance, decision-support tools, and hands-on practice, significantly enhanced students’ prescribing accuracy and confidence. Additionally, effective training in obtaining patient histories, identifying treatment goals, and recognising contraindications, drug interactions, and comorbidities was deemed critical for reducing medication errors. However, inconsistencies were observed in training content, duration, and delivery methods across institutions. Conclusion: The review highlights the importance of integrating a standardised, evidence-based safe prescribing curriculum that incorporates digital innovations, real-time feedback, and collaborative learning. This will equip future healthcare professionals with the necessary competencies to minimise prescribing errors and uphold patient safety.
- 3 November 2025
- Published by Servicio de Publicaciones de la Universidad de Murcia in Revista Española de Educación Médica
- Vol. 6 (6)
Open AccessSystematic review on safe prescribing training for medical students.
Introduction: Medication errors present a significant challenge to patient safety, stemming from inaccuracies in prescribing, dispensing, administration, and monitoring. These errors emphasise the urgent need to enhance safe prescribing training for medical students. This systematic review evaluates educational interventions aimed at improving prescribing competencies among medical undergraduates. Methods: A comprehensive search across Scopus, PubMed, Web of Science, ScienceDirect, and Google Scholar identified 16 primary studies that met the inclusion criteria. The interventions examined included case-based workshops, simulation-based training, e-learning platforms, interprofessional education, and pharmacist-led initiatives. Results: Findings consistently indicated that structured, longitudinal teaching, particularly when it integrates clinical relevance, decision-support tools, and hands-on practice, significantly enhanced students’ prescribing accuracy and confidence. Additionally, effective training in obtaining patient histories, identifying treatment goals, and recognising contraindications, drug interactions, and comorbidities was deemed critical for reducing medication errors. However, inconsistencies were observed in training content, duration, and delivery methods across institutions. Conclusion: The review highlights the importance of integrating a standardised, evidence-based safe prescribing curriculum that incorporates digital innovations, real-time feedback, and collaborative learning. This will equip future healthcare professionals with the necessary competencies to minimise prescribing errors and uphold patient safety.
- 1 August 2023
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 248 (16) , 1425-1436
Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering
Connective tissue growth factor (CTGF) is a distinct signaling molecule modulating many physiological and pathophysiological processes. This protein is upregulated in numerous fibrotic diseases that involve extracellular matrix (ECM) remodeling. It mediates the downstream effects of transforming growth factor beta (TGF-β) and is regulated via TGF-β SMAD-dependent and SMAD-independent signaling routes. Targeting CTGF instead of its upstream regulator TGF-β avoids the consequences of interfering with the pleotropic effects of TGF-β. Both CTGF and its upstream mediator, TGF-β, have been linked with the pathophysiology of glaucomatous optic neuropathy due to their involvement in the regulation of ECM homeostasis. The excessive expression of these growth factors is associated with glaucoma pathogenesis via elevation of the intraocular pressure (IOP), the most important risk factor for glaucoma. The raised in the IOP is due to dysregulation of ECM turnover resulting in excessive ECM deposition at the site of aqueous humor outflow. It is therefore believed that CTGF could be a potential therapeutic target in glaucoma therapy. This review highlights the CTGF biology and structure, its regulation and signaling, its association with the pathophysiology of glaucoma, and its potential role as a therapeutic target in glaucoma management.
- 1 August 2023
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 248 (16) , 1425-1436
Connective tissue growth factor: Role in trabecular meshwork remodeling and intraocular pressure lowering
Connective tissue growth factor (CTGF) is a distinct signaling molecule modulating many physiological and pathophysiological processes. This protein is upregulated in numerous fibrotic diseases that involve extracellular matrix (ECM) remodeling. It mediates the downstream effects of transforming growth factor beta (TGF-β) and is regulated via TGF-β SMAD-dependent and SMAD-independent signaling routes. Targeting CTGF instead of its upstream regulator TGF-β avoids the consequences of interfering with the pleotropic effects of TGF-β. Both CTGF and its upstream mediator, TGF-β, have been linked with the pathophysiology of glaucomatous optic neuropathy due to their involvement in the regulation of ECM homeostasis. The excessive expression of these growth factors is associated with glaucoma pathogenesis via elevation of the intraocular pressure (IOP), the most important risk factor for glaucoma. The raised in the IOP is due to dysregulation of ECM turnover resulting in excessive ECM deposition at the site of aqueous humor outflow. It is therefore believed that CTGF could be a potential therapeutic target in glaucoma therapy. This review highlights the CTGF biology and structure, its regulation and signaling, its association with the pathophysiology of glaucoma, and its potential role as a therapeutic target in glaucoma management.